Search Results

IPTROVIB RESPULES

LEVOSALBUTAMOL 1.25mg. IP + IPRATROPIUM BROMIDE 500mcg. IP

Send Enquiry

PRIMA

Respules

Packaging and packing Type

| 4x5x2.5ml

MRP :

₹380

PTR :

₹271.43

PTS :

₹244.29

A bronchodilator medication that makes breathing easier in chronic obstructive pulmonary disease individuals. Relaxes the airway smooth muscles and p... Read More

Composition

LEVOSALBUTAMOL 1.25mg. IP + IPRATROPIUM BROMIDE 500mcg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

A bronchodilator medication that makes breathing easier in chronic obstructive pulmonary disease individuals. Relaxes the airway smooth muscles and produces bronchodilation. A valuable approach for the maintenance and treatment of bronchospasm associated with chronic obstructive pulmonary disease, notably chronic bronchitis and emphysema. An effective bronchodilator drug for patients with acute asthma. (Faiqa Qureshi, 1998) Offers a statistically significant improvement in pulmonary function, as well as a reduction in the rate of hospitalizations. (G Rodrigo, 1999) Alleviates symptoms of chronic obstructive pulmonary disease, such as breathing difficulties, coughing, and wheezing. Effectively eases bronchospasms and enhances patency airways in the lungs. (Saab & Aboeed) Demonstrates a significantly greater improvement and longer duration of action than albuterol in patients with chronic obstructive airway disease. (S R Braun, 1989) A well-tolerated drug that provides significant bronchodilatory effect in subjects with mild persistent to moderate persistent asthma. (D A Handley, 2000) Produces significantly greater bronchodilation than racemic albuterol. (D’Alonzo, 2004) More effective medicine than albuterol in treating severely obstructed individuals and those not responding to metaproterenol. (S R Braun, 1989) A cost-effective alternative to racemic albuterol. (David M Schreck, 2005) Appears to be preferable to atropine in the treatment of obstructive airways disease. (Wanner, 1986)

Side Effects

Dryness in mouth, Breathlessness, Headache, Nausea, Vomiting, Diarrhea, Dizziness

Indication

Chronic obstructive pulmonary disorder , Bronchial asthma , Bronchitis , Emphysema , Bronchoconstriction

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner